64001-70-3 Usage
General Description
4-(1,3,4-Oxadiazol-2-yl)pyridine is a chemical compound with the molecular formula C7H5N3O. It is classified as a pyridine derivative and contains an oxadiazole functional group. 4-(1,3,4-OXADIAZOL-2-YL)PYRIDINE is commonly used in the field of medicinal chemistry for the development of pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable building block for the synthesis of novel compounds with potential biological activities. Additionally, 4-(1,3,4-Oxadiazol-2-yl)pyridine has also been studied for its potential use as a fluorescent probe in biological imaging and analytical chemistry applications. Overall, this chemical compound holds promise for various applications in the fields of chemistry, biology, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 64001-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,0,0 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 64001-70:
(7*6)+(6*4)+(5*0)+(4*0)+(3*1)+(2*7)+(1*0)=83
83 % 10 = 3
So 64001-70-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O/c1-3-8-4-2-6(1)7-10-9-5-11-7/h1-5H
64001-70-3Relevant articles and documents
Direct and Efficient Synthesis of Dimethylformamidrazones Using Bentriazole Vilsmeier Reagent
Katritzky, Alan R.,Huang, Tian-Bao,Voronkov, Michael V.
, p. 2246 - 2248 (2000)
-
Greener and rapid access to bio-active heterocycles: one-pot solvent-free synthesis of 1,3,4-oxadiazoles and 1,3,4-thiadiazoles
Polshettiwar, Vivek,Varma, Rajender S.
, p. 879 - 883 (2008/09/17)
A novel one-pot solvent-free synthesis of 1,3,4-oxadiazoles and 1,3,4-thiadiazoles by condensation of acid hydrazide and triethyl orthoalkanates under microwave irradiations is reported. This green protocol was catalyzed efficiently by solid supported NafionNR50 and phosphorus pentasulfide in alumina (P4S10/Al2O3) with excellent yields.
AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 53, (2010/02/09)
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceu
